Fresenius Medical Care Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Fresenius Medical Care de 21.7% y 3.6% por año respectivamente. Se prevé que el BPA crezca en un 21.2% al año. Se espera que la rentabilidad financiera sea de 7.4% en 3 años.

Información clave

20.7%

Tasa de crecimiento de los beneficios

20.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	16.0%
Tasa de crecimiento de los ingresos	3.5%
Rentabilidad financiera futura	7.4%
Cobertura de analistas	Good
Última actualización	25 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

OTCPK:FMCQ.F - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	21,276	1,180	1,597	2,662	14
12/31/2025	20,345	971	1,890	2,627	20
12/31/2024	19,620	709	1,822	2,407	19
12/31/2023	19,454	499	1,918	2,629	N/A
9/30/2023	19,463	450	1,799	2,509	N/A
6/30/2023	19,622	596	1,674	2,407	N/A
3/31/2023	19,554	602	1,401	2,152	N/A
12/31/2022	19,398	673	1,397	2,167	N/A
9/30/2022	19,048	763	1,444	2,237	N/A
6/30/2022	18,393	806	1,444	2,271	N/A
3/31/2022	17,957	878	1,576	2,441	N/A
12/31/2021	17,619	969	1,603	2,489	N/A
9/30/2021	17,372	918	1,477	2,405	N/A
6/30/2021	17,344	998	1,480	2,459	N/A
3/31/2021	17,581	1,131	2,869	3,857	N/A
12/31/2020	17,859	1,164	3,148	4,233	N/A
9/30/2020	18,039	1,330	3,299	4,420	N/A
6/30/2020	18,044	1,309	3,377	4,542	N/A
3/31/2020	17,832	1,212	1,832	3,075	N/A
12/31/2019	17,477	1,200	1,404	2,567	N/A
9/30/2019	17,196	1,282	1,367	2,494	N/A
6/30/2019	16,835	1,234	1,246	2,379	N/A
3/31/2019	16,704	1,974	1,065	2,182	N/A
12/31/2018	16,547	1,982	920	2,062	N/A
9/30/2018	16,676	1,951	766	1,892	N/A
6/30/2018	16,954	1,975	684	1,750	N/A
3/31/2018	17,211	1,250	982	1,977	N/A
12/31/2017	17,784	1,280	1,221	2,192	N/A
9/30/2017	17,771	1,249	N/A	2,436	N/A
6/30/2017	17,647	1,244	N/A	2,217	N/A
3/31/2017	17,201	1,239	N/A	1,938	N/A
12/31/2016	16,570	1,144	N/A	1,932	N/A
9/30/2016	16,101	1,063	N/A	1,648	N/A
6/30/2016	15,841	998	N/A	1,782	N/A
3/31/2016	15,402	933	N/A	1,491	N/A
12/31/2015	15,455	955	N/A	1,767	N/A
9/30/2015	15,345	939	N/A	1,791	N/A
6/30/2015	15,246	948	N/A	1,914	N/A
3/31/2015	15,428	977	N/A	2,044	N/A
12/31/2014	13,329	864	N/A	1,538	N/A
9/30/2014	12,413	839	N/A	1,476	N/A
6/30/2014	11,112	775	N/A	1,283	N/A
3/31/2014	10,882	791	N/A	1,329	N/A
12/31/2013	10,816	806	N/A	1,478	N/A
9/30/2013	10,881	752	N/A	1,491	N/A
6/30/2013	11,135	781	N/A	1,498	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (21.7% al año) de FMCQ.F es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (21.7% al año) de FMCQ.F crezcan más rápidamente que el mercado US (14.4% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de FMCQ.F crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.6% al año) de FMCQ.F crezcan más despacio que el mercado de US (7.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.6% al año) de FMCQ.F crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de FMCQ.F sea baja dentro de 3 años (7.4%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Fresenius Medical Care Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Fresenius Medical Care AG Provides Earnings Guidance for Fiscal Year 2024

Fresenius Medical Care AG & Co. Revises Earnings Guidance for the Year 2023

Fresenius Medical Care AG & Co. KGaA Revises Earnings Guidance for the Full Year 2022

Fresenius Medical Care AG & Co. KGaA Provides Earnings Guidance for the Second Half of 2022

Fresenius Medical Care Ag & Co. Kgaa Provides Earnings Forecast for the Year 2022

Fresenius Medical Care Confirms Earnings Guidance for the Fiscal Year 2021

Recent updates

Fresenius Medical Care Launches Augmented Reality for Training on Kidney Replacement Therapy Device

Fresenius Medical Care AG Appoints Jörg Häring as New Global Head of Legal, Compliance and Human Resources and Also Assume the Role of Labor Director, Effective from June 1, 2024

Fresenius Medical Care AG Proposes Dividend for the Fiscal Year 2023

Fresenius Medical Care AG Provides Earnings Guidance for Fiscal Year 2024

Fresenius Medical Care Brings Dialysis Therapy to Kidney Disease Patients in the U.S

Fresenius Medical Care Enters into Favorable Settlement Agreement with U. S. Government

Fresenius Medical Care AG & Co. Revises Earnings Guidance for the Year 2023

Fresenius Medical Care AG & Co. KGaA to Report Fiscal Year 2023 Final Results on Mar 22, 2024

An Unknown buyer entered into an agreement to acquire National Cardiovascular Partners, LP from Fresenius Medical Care AG & Co. KGaA (XTRA:FME)

Fresenius Medical Care AG & Co. KGaA to Report Q1, 2024 Results on May 07, 2024

Fresenius Medical Care Appoints Craig Cordola as New Management Board Member for Care Delivery

Fresenius Medical Care Achieves Key Ai Milestone with First-Phase Completion of Largest Global Dialysis Clinical Dataset

Fresenius Medical Care Announces Fda Clearance of Versi(R)Hd with Guideme Software

An unknown buyer acquired Local dialysis service provider business from Fresenius Medical Care AG & Co. KGaA (XTRA:FME).

Fresenius Medical Care Announces Executive Changes

Fresenius Medical Care participated Announces Breakthrough Study Demonstrates That High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality Rates

Fresenius Medical Care AG & Co. KGaA Announces CEO Changes

Fresenius Medical Care AG & Co. KGaA, Annual General Meeting, May 16, 2023

Fresenius Medical Care AG & Co. KGaA to Report Q2, 2023 Results on Aug 02, 2023

Fresenius Medical Care AG & Co. KGaA Revises Earnings Guidance for the Full Year 2022

Fresenius Medical Care AG & Co. KGaA Provides Earnings Guidance for the Second Half of 2022

Fresenius Medical Care AG & Co. KGaA to Report Q3, 2022 Final Results on Nov 09, 2022

Fresenius Medical Care Appoints Nwamaka (Amaka) Eneanya as Head of Strategy and Operations for the Company's Global Medical Office

Fresenius Medical Care AG & Co. KGaA Proposes Dividend, Due on 17 May 2022

Fresenius Medical Care Ag & Co. Kgaa Provides Earnings Forecast for the Year 2022

Fresenius Medical Care Reportedly in Talks to Buy Dmed Diyaliz

Fresenius Medical Care AG & Co. KGaA Launches New Mobile App to Empower and Engage Nurses

Fresenius Medical Care Approves Dividend for the Fiscal Year 2020

Fresenius Medical Care Confirms Earnings Guidance for the Fiscal Year 2021

Fresenius Medical Care AG & Co. KGaA to Report Fiscal Year 2020 Final Results on Mar 23, 2021

Fresenius Medical Care AG & Co. KGaA to Report Q3, 2021 Results on Nov 02, 2021

Fresenius Medical Care's Frenova Enrolls Patients in Initiative to Build Large Genomic Registry Targeting Kidney Disease

Fresenius Medical Care AG & Co. KGaA, Annual General Meeting, May 20, 2021

Fresenius Medical Care AG & Co. KGaA to Report Q1, 2020 Results on May 06, 2020

Fresenius Medical Care AG & Co. KGaA to Report Q2, 2020 Results on Jul 30, 2020

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento